Age- and gender-related differences of plasma prothrombin activity levels [3]

Thrombosis and Haemostasis

Volumn 97, Issue 6, 2007, Pages 1052-1053

  Sakata, Toshiyuki ^a   Okamoto, Akira ^a   Morita, Takashi ^b   Kokubo, Yoshihiro ^a   Sato, Kiyoshi ^a   Okayama, Akira ^a   Tomoike, Hitonobu ^a   Miyata, Toshiyuki ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; PROTHROMBIN;

ADULT; AGED; AGING; BLOOD ANALYSIS; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; GERIATRIC DISORDER; GROUPS BY AGE; HUMAN; HYPERCOAGULABILITY; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN FUNCTION; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; AGING; BLOOD COAGULATION; DOWN-REGULATION; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; PROTHROMBIN; REFERENCE VALUES; SEX DISTRIBUTION;

EID: 34250624845     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH07-01-0019     Document Type: Letter

References (16)

1. White RH. The epidemiology of venous thromboembolism. Circulation 2003; 107:14-8.
2. Feinbloom D, Bauer KA. Assessment of hemostatic risk factors in predicting arterial thrombotic events. Arterioscler Thromb Vasc Biol 2005; 25: 2043-2053.
3. Couturaud F, Kearon C, Leroyer C, et al. Incidence of venous thromboembolism in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. Thromb Haemost 2006; 96: 744-749.
4. Mannami T, Baba S, Ogata J. Strong and significant relationships between aggregation of major coronary risk factors and the acceleration of carotid atherosclerosis in the general population of a Japanese city: the Suita Study. Arch Intern Med 2000; 160: 2297-2303.
5. Tofler GH, Massaro J, Levy D, et al. Relation of the prothrombotic state to increasing age (from the Framingham Offspring Study). Am J Cardiol 2005; 96: 1280-1283.
6. Butenas S, van't Veer C, Mann KG. "Normal" thrombin generation. Blood 1999; 94: 2169-2178.
7. Poort SR, Rosendaal FR, Reitsma PH, et al. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-3703.
8. Ye Z, Liu EH, Higgins JP, et al. Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls. Lancet 2006; 367: 651-658.
9. Miyata T, Kawasaki T, Fujimura H, et al. The prothrombin gene G20210A mutation is not found among Japanese patients with deep vein thrombosis and healthy individuals. Blood Coagul Fibrinolysis 1998; 9: 451-452.
10. Yamada D, Morita T. CA-1 method, a novel assay for quantification of normal prothrombin using a Ca2+-dependent prothrombin activator, carinactivase-1. Thromb Res 1999; 94: 221-226.
11. Bauer KA, Weiss LM, Sparrow D, et al. Aging-associated changes in induces of thrombin generation and protein C activation in humans. J Clin Invest 1987; 80; 1527-1534.
12. Mari D, Mannucci PM, Coppola R, et al. Hypercoagulability in centenarians: the paradox of successful aging. Blood 1995; 85: 3144-3149.
13. Miyata T, Kimura R, Kokubo Y, et al. Genetic risk factors for deep vein thrombosis among Japanese: Importance of protein S K196E mutation. Int J Hematol 2006; 83; 217-223.
14. White RH, Dager WE, Zhou H, et al. Racial and gender differences in the incidence of recurrent venous thromboembolism. Thromb Haemost 2006; 96: 267-273.
15. Sakata T, Kario K, Matsuo T, et al. Suppression of plasma activated factor VII levels by warfarin therapy. Arterioscler Thromb Vasc Biol 1995; 15; 241-246.
16. White RH, McBurnie MA, Manolio T, et al. Oral anticoagulation in patients with atrial fibrillation: adherence with guidelines in an elderly cohort. Am J Med 1999; 106; 165-171.